Font Size




Menu Style

Return to Menu

Correlates of Protection for Next Generation Influenza Vaccines:
Lessons Learned from the Covid Pandemic

Destination Slides 073.jpg

1 - 3 March 2023


The COVID-19 pandemic has had a seismic impact on many of the key drivers in the world of vaccine research, development, clinical evaluation and regulatory approval. Lessons have been learned but core objectives remain.
As next generation influenza vaccine technologies are developed, new immunological assays and immune correlates of protection will be needed to estimate the immunogenicity and protective efficacy of these vaccines.This will be more fully considered within the context of the pandemic and SARS CoV-2 research.

This conference aims to bring together scientists from academia, industry, and government public health, standardisation and regulatory agencies that develop and evaluate seasonal and pandemic influenza vaccines with the following objectives:


  • to identify the most relevant immunological assays needed for evaluation of next-generation influenza vaccines
  • to discuss the path forward for development, harmonization and standardisation of new assays
  • to develop strategies to investigate the immune correlates of protection for next-generation vaccines

The meeting will be attended by key opinion leaders and decision makers in influenza research/policy.